Rago T, Di Coscio G, Basolo F, Scutari M, Elisei R, Berti P, Miccoli P, Romani R, Faviana P, Pinchera A, Vitti P
Department of Endocrinology, University of Pisa, Italy.
Clin Endocrinol (Oxf). 2007 Jan;66(1):13-20. doi: 10.1111/j.1365-2265.2006.02677.x.
The cytological patterns of follicular and Hupsilonrthle cell nodules are included among the indeterminate results of fine-needle aspiration cytology, because distinction between benign and malignant lesion can only be made on histological criteria. The diagnostic value of atypia at cytology, clinical parameters and echographic patterns were examined to establish the risk of malignancy in 505 patients with follicular and Hupsilonrthle cell thyroid nodules at cytology.
The study included 505 consecutive patients who had undergone thyroidectomy from the period 2002-2005.
Histological diagnosis of malignancy was carried out in 125 of 505 (25%) patients, the follicular variant of papillary carcinoma being the most frequent histotype. Only atypia at cytology (P < 0.0001) and spot microcalcifications at ultrasound (P = 0.009) were predictive of malignancy. Male gender, normal thyroid volume, single nodularity, nodule hypoechogenicity, size and blurred margins were associated with malignancy, although not significantly. An arbitrary clinical score allowed the identification of patients with high (41%, 110 patients) and low (16%, 242 patients) risk of malignancy. Combining the clinical score with the presence of atypia at cytology we could identify 30 patients (6%) in whom the risk of malignancy was as high as 63%.
Twenty-five per cent of patients with a cytological result of follicular and Hupsilonrthle cell thyroid lesion had a final diagnosis of malignancy. Only atypia at cytology and spot microcalcifications at thyroid ultrasound were significantly associated with malignancy. Other clinical parameters and thyroid ultrasound patterns can be used to set up a clinical score useful for predicting the individual risk of malignancy before surgery.
滤泡性和许特耳细胞结节的细胞学表现被列入细针穿刺细胞学检查的不确定结果之中,因为良性和恶性病变只能依据组织学标准来区分。本研究检测了细胞学非典型性、临床参数及超声表现的诊断价值,以确定505例细胞学检查为滤泡性和许特耳细胞甲状腺结节患者的恶性风险。
本研究纳入了2002年至2005年期间连续接受甲状腺切除术的505例患者。
505例患者中有125例(25%)经组织学诊断为恶性,乳头状癌的滤泡变异型是最常见的组织学类型。只有细胞学非典型性(P<0.0001)和超声检查发现的点状微钙化(P=0.009)可预测恶性病变。男性、甲状腺体积正常、单发结节、结节低回声、大小及边界不清与恶性病变有关,尽管无显著相关性。一个任意设定的临床评分可识别出恶性风险高(41%,110例患者)和低(16%,242例患者)的患者。将临床评分与细胞学非典型性相结合,我们可以识别出30例(6%)恶性风险高达63%的患者。
细胞学检查结果为滤泡性和许特耳细胞甲状腺病变的患者中有25%最终诊断为恶性。只有细胞学非典型性和甲状腺超声检查发现的点状微钙化与恶性病变显著相关。其他临床参数和甲状腺超声表现可用于建立一个临床评分,有助于在手术前预测个体的恶性风险。